• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

枸橼酸西地那非对原位前列腺癌生长和转移模型的影响。

Effect of sildenafil citrate on an orthotopic prostate cancer growth and metastasis model.

作者信息

Qian Chao-Nan, Takahashi Masayuki, Kahnoski Richard J, Teh Bin Tean

机构信息

Laboratory of Cancer Genetics, Van Andel Research Institute, Grand Rapids, MI, USA.

出版信息

J Urol. 2003 Sep;170(3):994-7. doi: 10.1097/01.ju.0000080321.99119.df.

DOI:10.1097/01.ju.0000080321.99119.df
PMID:12913757
Abstract

PURPOSE

We characterized the effects of sildenafil citrate on the growth and metastasis of human prostate cancer cells in nude mice.

MATERIALS AND METHODS

The androgen independent human prostate cancer cell line PC-3 was inoculated into the prostate of nude mice to produce orthotopic primary prostate cancers and metastases. Sildenafil citrate gavage was started on day 31 after tumor cell inoculation and given every other day 15 times (30 days). The 7 mice in the low dose group received 25 mg/kg body weight sildenafil citrate per gavage, while the 7 in the high dose group received 50 mg/kg body weight sildenafil citrate and the 9 in the control group received water. Autopsy was performed on day 75 to evaluate primary tumor growth and metastasis. Plasma cyclic guanosine monophosphate concentrations were measured after the single dose of 50 mg/kg sildenafil citrate in the mice.

RESULTS

Plasma cyclic guanosine monophosphate concentration increased 4-fold 1 hour after sildenafil citrate administration. The plasma concentration decreased rapidly and returned to normal after 8 hours. There was no significant difference in tumor weight between any of the 3 groups. The number of metastatic lymph nodes correlated significantly with primary tumor weight (p = 0.03) with a correlation coefficient of 0.454 but there was no significant correlation between the number of involved lymph nodes and sildenafil administration. Distant metastases were not significantly promoted by sildenafil administration.

CONCLUSIONS

Incontinuous oral administration of sildenafil citrate did not promote primary tumor growth and metastasis in an orthotopic prostate cancer model.

摘要

目的

我们研究了枸橼酸西地那非对裸鼠体内人前列腺癌细胞生长和转移的影响。

材料与方法

将雄激素非依赖性人前列腺癌细胞系PC-3接种到裸鼠前列腺中,以产生原位原发性前列腺癌和转移灶。在肿瘤细胞接种后第31天开始进行枸橼酸西地那非灌胃,每隔一天给药1次,共给药15次(30天)。低剂量组的7只小鼠每次灌胃给予25mg/kg体重的枸橼酸西地那非,高剂量组的7只小鼠每次灌胃给予50mg/kg体重的枸橼酸西地那非,对照组的9只小鼠给予水。在第75天进行尸检,以评估原发性肿瘤的生长和转移情况。在小鼠单次给予50mg/kg体重的枸橼酸西地那非后,测量血浆环磷酸鸟苷浓度。

结果

给予枸橼酸西地那非1小时后,血浆环磷酸鸟苷浓度增加了4倍。血浆浓度迅速下降,8小时后恢复正常。3组之间的肿瘤重量没有显著差异。转移淋巴结的数量与原发性肿瘤重量显著相关(p = 0.03),相关系数为0.454,但受累淋巴结数量与西地那非给药之间没有显著相关性。西地那非给药并未显著促进远处转移。

结论

在原位前列腺癌模型中,间断口服枸橼酸西地那非不会促进原发性肿瘤的生长和转移。

相似文献

1
Effect of sildenafil citrate on an orthotopic prostate cancer growth and metastasis model.枸橼酸西地那非对原位前列腺癌生长和转移模型的影响。
J Urol. 2003 Sep;170(3):994-7. doi: 10.1097/01.ju.0000080321.99119.df.
2
Inhibition of PC-3 human androgen-independent prostate cancer and its metastases by cytotoxic somatostatin analogue AN-238.细胞毒性生长抑素类似物AN-238对PC-3人雄激素非依赖性前列腺癌及其转移的抑制作用。
Cancer Res. 1999 Apr 15;59(8):1947-53.
3
Success of sildenafil for erectile dysfunction in men treated with brachytherapy or external beam radiation for prostate cancer.西地那非对接受近距离放射疗法或外照射放疗的前列腺癌男性勃起功能障碍的治疗效果。
Can J Urol. 2004 Dec;11(6):2450-5.
4
The effect of sildenafil on the altered thoracic aorta smooth muscle responses in rat pre-eclampsia model.西地那非对大鼠子痫前期模型胸主动脉平滑肌反应改变的影响。
Eur J Pharmacol. 2008 Jul 28;589(1-3):180-7. doi: 10.1016/j.ejphar.2008.04.034. Epub 2008 Jun 4.
5
Systemic administration of phosphodiesterase V inhibitor, sildenafil citrate, for attenuation of cerebral vasospasm after experimental subarachnoid hemorrhage.经系统给药磷酸二酯酶V抑制剂枸橼酸西地那非,以减轻实验性蛛网膜下腔出血后的脑血管痉挛。
Neurosurgery. 2006 Nov;59(5):1102-7; discussion 1107-8. doi: 10.1227/01.NEU.0000245605.22817.44.
6
The effect of sildenafil citrate on bladder outlet obstruction: a mouse model.枸橼酸西地那非对膀胱出口梗阻的影响:小鼠模型
BJU Int. 2009 Jul;104(2):252-6. doi: 10.1111/j.1464-410X.2008.08324.x. Epub 2008 Dec 19.
7
Improved metastatic animal model of human prostate carcinoma using surgical orthotopic implantation (SOI).使用手术原位植入(SOI)改进的人前列腺癌转移动物模型。
Anticancer Res. 1999 Sep-Oct;19(5B):4199-202.
8
Systemic interleukin 2 therapy for human prostate tumors in a nude mouse model.裸鼠模型中系统性白细胞介素2治疗人类前列腺肿瘤的研究
Clin Cancer Res. 1998 Aug;4(8):2009-14.
9
Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease.静脉注射西地那非对患有先天性心脏病的儿童是一种有效的肺血管扩张剂。
Circulation. 2003 Sep 9;108 Suppl 1:II167-73. doi: 10.1161/01.cir.0000087384.76615.60.
10
The efficacy of sildenafil citrate following radiation therapy for prostate cancer: temporal considerations.枸橼酸西地那非在前列腺癌放射治疗后的疗效:时间因素考量
J Urol. 2005 Jul;174(1):258-62; discussion 262. doi: 10.1097/01.ju.0000164286.47518.1e.

引用本文的文献

1
Phosphodiesterase 5 inhibitor sildenafil potentiates the antitumor activity of cisplatin by ROS-mediated apoptosis: a role of deregulated glucose metabolism.磷酸二酯酶 5 抑制剂西地那非通过 ROS 介导的细胞凋亡增强顺铂的抗肿瘤活性:葡萄糖代谢失调的作用。
Apoptosis. 2022 Aug;27(7-8):606-618. doi: 10.1007/s10495-022-01741-0. Epub 2022 Jun 20.
2
Prostate Cancer Cell Phenotypes Remain Stable Following PDE5 Inhibition in the Clinically Relevant Range.在临床相关范围内,磷酸二酯酶5(PDE5)抑制后前列腺癌细胞表型保持稳定。
Transl Oncol. 2020 Sep;13(9):100797. doi: 10.1016/j.tranon.2020.100797. Epub 2020 May 23.
3
Is there a relationship between phosphodiesterase type 5 inhibitors and biochemical recurrence after radical prostatectomy: a systematic review and meta-analysis.
5型磷酸二酯酶抑制剂与前列腺癌根治术后生化复发之间存在关联吗:一项系统评价与荟萃分析
Int Urol Nephrol. 2018 Dec;50(12):2113-2121. doi: 10.1007/s11255-018-1982-y. Epub 2018 Sep 19.
4
Repurposing drugs in oncology (ReDO)-selective PDE5 inhibitors as anti-cancer agents.肿瘤学中药物的重新利用(ReDO)——选择性磷酸二酯酶5抑制剂作为抗癌药物
Ecancermedicalscience. 2018 Apr 11;12:824. doi: 10.3332/ecancer.2018.824. eCollection 2018.
5
Phosphodiesterase type 5 and cancers: progress and challenges.5型磷酸二酯酶与癌症:进展与挑战
Oncotarget. 2017 Oct 12;8(58):99179-99202. doi: 10.18632/oncotarget.21837. eCollection 2017 Nov 17.
6
Let's rethinking about the safety of phosphodiesterase type 5 inhibitor in the patients with erectile dysfunction after radical prostatectomy.让我们重新思考5型磷酸二酯酶抑制剂在前列腺癌根治术后勃起功能障碍患者中的安全性。
J Exerc Rehabil. 2016 Jun 30;12(3):143-7. doi: 10.12965/jer.1632646.323. eCollection 2016 Jun.
7
The Association between Phosphodiesterase Type 5 Inhibitors and Prostate Cancer: Results from the REDUCE Study.磷酸二酯酶 5 抑制剂与前列腺癌的相关性:来自 REDUCE 研究的结果。
J Urol. 2016 Sep;196(3):715-20. doi: 10.1016/j.juro.2016.03.172. Epub 2016 Apr 5.
8
Potential therapeutic applications of phosphodiesterase inhibition in prostate cancer.磷酸二酯酶抑制在前列腺癌中的潜在治疗应用。
World J Urol. 2013 Apr;31(2):325-30. doi: 10.1007/s00345-012-0848-7. Epub 2012 Mar 2.
9
Sildenafil and cardiomyocyte-specific cGMP signaling prevent cardiomyopathic changes associated with dystrophin deficiency.西地那非和心肌细胞特异性环磷酸鸟苷信号传导可预防与肌营养不良蛋白缺乏相关的心肌病变化。
Proc Natl Acad Sci U S A. 2008 May 13;105(19):7028-33. doi: 10.1073/pnas.0710595105. Epub 2008 May 12.
10
Semiquantitative imaging measurement of baseline and vasomodulated normal prostatic blood flow using sildenafil.使用西地那非对基线和血管调节的正常前列腺血流进行半定量成像测量。
Int J Impot Res. 2007 Jan-Feb;19(1):110-3. doi: 10.1038/sj.ijir.3901486. Epub 2006 May 25.